arrow
S

Saketh R. Guntupalli

university of colorado cancer center
H指数:25
被引数:3,130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估恶性腹水细胞学在子宫内膜癌中预后意义:一项NRG Oncology/妇科肿瘤学组关于GOG-210方案的研究

2025-09-030
PRE
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

一项关于rucaparib与安慰剂在转移性和复发性子宫内膜癌维持治疗中使用的II期、随机、双盲研究

2025-07-220
PRE
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner
2024-08-130
PRE
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
2024-05-071
PRE
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
2019-02-0135
OAAI
Receipt of adjuvant endometrial cancer treatment updates according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
2018-11-0113
OAAI